In this study, we demonstrate that Nerofe combined with low-dose doxorubicin (ldDox) induces IL-2 expression in human pancreatic adenocarcinoma cells (PANC-1) through activation of the AP-1 transcription factor. The gene discussed is FOS; the disease is pancreatic adenocarcinoma.